Smart Innovation
Antimicrobial resistance (AMR)
AMR develops when bacteria, fungi or viruses are exposed to antibiotics, antifungals or antivirals. As a result, the antimicrobials become ineffective and infections may persist. In addition, medical interventions including surgery, chemotherapy and stem cell therapy may become impossible.
AMR is considered the biggest global threat of Health and Food Safety.
AMR Insights
For Researchers and Entrepreneurs who wish to investigate, develop and commercialize novel vaccines, diagnostics and antimicrobials to prevent Antimicrobial resistance, AMR Insights offers selected, global information and data, specific education and extensive networking and partnering opportunities.
AMR Insights is for:
- Researchers at Universities and University Medical Centers
- Researchers at Research Institutes
- R&D professionals in Pharma, Biopharma and Diagnostics companies
- Entrepreneurs in start-up’s and spin off companies
- Innovators, Venture Capitalists.
Latest Topics
-
17 October 2024Unveiling Encrypted Antimicrobial Peptides from Cephalopods’ Salivary Glands: A Proteolysis-Driven Virtual Approach
This study reveals a potential reservoir of antimicrobial peptides (AMPs) in marine cephalopod salivary glands. A composite protein database of 5,412,039 canonical and noncanonical proteins from 14 cephalopod species was digested, yielding over 9 million nonredundant peptides. These peptides were screened using various tools, focusing on antimicrobial activity and structural uniqueness. Five datasets were released, […]
Read more... -
17 October 2024Telemedicine-based antibiotic stewardship program in pediatrics: study protocol of a stepped wedge cluster randomized trial—the TeleKasper study
The TeleKasper study aims to implement a nationwide antibiotic stewardship program in non-university children’s hospitals in Germany. The telemedicine consultation service, which uses an app as a communication tool, will reduce overall antibiotic consumption by 20%. The primary outcome is a 20% reduction in antibiotic consumption per 100 patient days. This approach aims to promote […]
Read more... -
17 October 2024C-CAMP partners with ICARS to support innovative One Health solutions for AMR challenges
The International Centre for Antimicrobial Resistance Solutions (ICARS) has partnered with the Centre for Cellular and Molecular Platforms (C-CAMP) to fund and support innovative solutions to Antimicrobial Resistance (AMR) in India. The partnership aims to jointly mobilize additional funding and develop solutions impacting One Health through an AMR Challenge. The collaboration will focus on identifying, […]
Read more...
More news related to Smart innovation